These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6362960)

  • 1. Captopril enhances vascular and adrenal responsiveness to angiotensin II in essential hypertension.
    Koletsky RJ; Gordon MB; LeBoff MS; Moore TJ; Dluhy RG; Hollenberg NK; Williams GH
    Clin Sci (Lond); 1984 Mar; 66(3):299-305. PubMed ID: 6362960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responses to converting enzyme and renin inhibition. Role of angiotensin II in humans.
    Fisher ND; Allan D; Kifor I; Gaboury CL; Williams GH; Moore TJ; Hollenberg NK
    Hypertension; 1994 Jan; 23(1):44-51. PubMed ID: 8282330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Converting-enzyme inhibition corrects the altered adrenal response to angiotensin II in essential hypertension.
    Taylor T; Moore TJ; Hollenberg NK; Williams GH
    Hypertension; 1984; 6(1):92-9. PubMed ID: 6198274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma angiotensin II concentration regulates vascular but not adrenal responsiveness to restriction of sodium intake in normal man.
    Dawson-Hughes BF; Moore TJ; Dluhy RG; Hollenberg NK; Williams GH
    Clin Sci (Lond); 1981 Nov; 61(5):527-34. PubMed ID: 7026131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effects of captopril on blood pressure and circulating hormone levels in salt-replete and depleted normal subjects and essential hypertensive patients.
    Millar JA; McGrath BP; Matthews PG; Johnston CI
    Clin Sci (Lond); 1981 Jul; 61(1):75-83. PubMed ID: 7018813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caffeine attenuates the renal vascular response to angiotensin II infusion.
    Brown NJ; Ryder D; Nadeau J
    Hypertension; 1993 Dec; 22(6):847-52. PubMed ID: 8244516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension.
    Shoback DM; Williams GH; Moore TJ; Dluhy RG; Podolsky S; Hollenberg NK
    J Clin Invest; 1983 Dec; 72(6):2115-24. PubMed ID: 6358261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced slow-pressor response to angiotensin II in spontaneously hypertensive rats.
    Li P; Jackson EK
    J Pharmacol Exp Ther; 1989 Dec; 251(3):909-21. PubMed ID: 2557422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The pressor and adrenal responses to angiotensin II in patients with normoreninemic essential hypertension--the influence of sodium intake and captopril].
    Kuroda K; Ito K; Sakaguchi A; Kimura G; Uda M; Kojima S; Natsume T; Sakamoto N; Tsuchiya M; Tanaka T
    Nihon Jinzo Gakkai Shi; 1983 Feb; 25(2):179-88. PubMed ID: 6353007
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of captopril and hydrochlorothiazide on the response to pressor agents in hypertensives.
    Fruncillo RJ; Rotmensch HH; Vlasses PH; Koplin JR; Swanson BN; Ferguson RK
    Eur J Clin Pharmacol; 1985; 28(1):5-9. PubMed ID: 3886401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged converting enzyme inhibition in non-modulating hypertension.
    Dluhy RG; Smith K; Taylor T; Hollenberg NK; Williams GH
    Hypertension; 1989 Apr; 13(4):371-7. PubMed ID: 2538393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid modulation of renal and adrenal responsiveness to angiotensin II.
    Conlin PR; Moore TJ; Williams GH; Hollenberg NK
    Hypertension; 1993 Dec; 22(6):832-8. PubMed ID: 7503952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
    Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The renin--angiotensin--aldosterone system in the maintenance of blood pressure, aldosterone secretion and sodium balance in normotensive subjects.
    MacGregor GA; Markandu ND; Roulston JE; Jones JC; Morton JJ
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():95s-99s. PubMed ID: 7004744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous angiotensin II as a determinant of sodium-modulated changes in tissue responsiveness to angiotensin II in normal man.
    Shoback DM; Williams GH; Hollenberg NK; Davies RO; Moore TJ; Dluhy RG
    J Clin Endocrinol Metab; 1983 Oct; 57(4):764-70. PubMed ID: 6309884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preservation of renal function by angiotensin during chronic adrenergic stimulation.
    Lohmeier TE; Yang HM
    Hypertension; 1991 Mar; 17(3):278-87. PubMed ID: 1999358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced renal angiotensin II subtype 1 receptor responses in the spontaneously hypertensive rat.
    Kost CK; Jackson EK
    Hypertension; 1993 Apr; 21(4):420-31. PubMed ID: 8458644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular regulation during angiotensin converting enzyme inhibition with captopril in diabetes-associated hypertension.
    Beretta-Piccoli C; Ziegler WH; Antonini P; Bernasconi-Zapf M; Kressebuch H; Pianezzi F
    J Hypertens; 1990 Jul; 8(7):671-8. PubMed ID: 2168458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The adrenal receptor for angiotensin II is altered in essential hypertension.
    Williams GH; Hollenberg NK; Moore TJ; Swartz SL; Dluhy RG
    J Clin Invest; 1979 Mar; 63(3):419-27. PubMed ID: 219037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal response to captopril reflects state of local renin system in healthy humans.
    Fisher ND; Price DA; Litchfield WR; Williams GH; Hollenberg NK
    Kidney Int; 1999 Aug; 56(2):635-41. PubMed ID: 10432403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.